IPH (IPH) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
9 Jul, 2026Opening remarks and agenda
Meeting was live-streamed, with shareholders able to submit questions in advance.
Board members, senior executives, and auditors were introduced, and the Notice of Meeting was taken as read.
The agenda included financial results, market challenges, remuneration framework enhancements, board renewal, and CEO succession.
Financial performance review
Statutory net profit after tax rose to AUD 68.8 million from AUD 60.8 million, with underlying EBITDA up 7.3% to AUD 120.6 million.
Group revenue was AUD 356.3 million, slightly down from AUD 359.9 million, with a leverage ratio of 1.9x.
Final dividend declared at AUD 19.50 per share, up 4% year-on-year.
FY25 revenue reached AUD 710.3 million, with underlying EBITDA at AUD 207.2 million, driven by Canadian acquisitions.
Like-for-like revenue was flat, with EBITDA down 4%; Australia/NZ saw slight revenue growth but EBITDA declined 2%.
Asia revenue was flat, EBITDA down 1.7%; filings in Asia increased 16.5%.
Canada faced CIPO system disruptions but saw above-target synergies from acquisitions.
For the first four months of FY26, group revenue was AUD 241.7 million, with like-for-like revenue up 3.3% in Asia and 3.1% in Canada.
Board and executive committee updates
Board renewal continued with Kate Mason joining in September 2025; Xingming Kean retired at the AGM.
CEO Andrew Blattman announced intention to retire in the second half of 2026; succession process to consider internal and external candidates.
John Atkin and Vicki Carter stood for re-election as non-executive directors; Kate Mason stood for election.
Latest events from IPH
- Underlying NPAT up 20% to $61.0m, with strong growth in Australia/NZ and Asian filings up 10%.IPH
H1 20258 Jul 2026 - Strong growth, strategic integration, and board renewal marked the year, with focus on organic gains.IPH
AGM 202425 Jun 2026 - EBITDA and NPAT rose 15% and 14%, with leverage at 1.9x and strong Canadian integration.IPH
H2 202428 May 2026 - Revenue up 16.5% to AUD 710.3m, with strong cash flow, higher dividends, and cost savings ahead.IPH
H2 202528 May 2026 - NPAT up 10.5% to $41.2m, revenue up 6.5%, and 19.0c dividend with buy-back in March 2026.IPH
H1 202628 May 2026 - IPH acquires Bereskin & Parr, expanding in Canada and launching a major equity raise.IPH
Investor Presentation13 Jun 2025 - Market-leading IPH Limited drives growth through innovation, efficiency, and global expansion.IPH
Company Presentation6 Jun 2025